The technology provides a universal solution to respiratory viruses, regardless of an individual's immune history – for example, people who do not sufficiently respond to a vaccine, or don't get vaccinated

This group will lead the development of a Call to Action to advocate for better access to treatments, in particular COVID- 19.

The majority of RSV infections in young children are managed in primary care, however, the disease burden in this setting remains poorly defined.

A new joint action focusing on tackling chronic respiratory diseases was recently launched. Backed by the EU4Health programme, the 3-year initiative aims to improve lung health across Europe through innovative digital health technologies.

Use these materials to raise awareness about new immunisation products to protect infants in early life from a top cause of severe respiratory infections in children.

ECDC has launched an online platform, RespiCompass, which uses mathematical modelling to simulate respiratory disease dynamics under different scenarios.

Strengthening of nonpharmaceutical interventions changed the epidemic dynamics of pediatric infectious diseases, with a trend toward older hospitalized children.

Based on the current risk assessment, WHO advises against any travel or trade restrictions related to current trends in acute respiratory infections.